The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
As you can see below, at the end of June 2024, Pfizer had US$69.9b of debt, up from US$65.7b a year ago. Click the image for ...
Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...
New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...
Shares of Pfizer Inc. PFE dropped 0.81% to $29.42 Friday, on what proved to be an all-around mixed trading session for the ...
Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been ...
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use ...
Secret History on MSN5h
What If a COVID Vaccine Were Available Tomorrow?With COVID cases on the rise in many countries, the race to find an effective vaccine is becoming a more pressing concern ...
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
Este químico de processos ajudou a aumentar a escala de produção de um componente essencial do antiviral para COVID-19 ...
Este químico de procesos contribuyó al escalado de la producción de un componente clave de un antiviral contra COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback